Business Travel Is Getting More Expensive. What Should Companies Measure Next?
Deloitte reports rising corporate travel budgets, but budget growth does not show whether a particular trip produced a commercial result.
What do the new budget figures tell us?
Deloitte’s 2026 Corporate Travel Study reports an average budget increase of 12% for 2026, and surveyed managers expect a 10% increase for 2027. The report says travel spend is growing roughly twice as fast as trip volume. These are survey findings and expectations, not a count of trips that have already happened or a measure of the return from any one trip.
The study describes a survey of about 150 US-based travel managers. It also reports that 60% identify booking compliance as a cost-control priority and 44% say their company has made pre-trip approval more rigorous. Those figures describe what surveyed managers report; they do not establish that tighter controls improve commercial outcomes.
What does a traveler survey add, and what can it not show?
In its published early findings, The Sales Traveler reports that 74% of respondents said in-person interaction is decisive in late-stage deals. The published provenance line is: 2026 Business Travel Survey, Wave 1 early responses · n=187 at time of writing, self-selected sample weighted to revenue-facing roles. The survey was still collecting responses, and the result is self-reported. It is a directional signal about respondents’ views, not a representative estimate of all business travelers or a measurement that travel caused a deal to advance. See the published findings and sample limits.
The Deloitte and Sales Traveler surveys answer different questions and use different populations. Their percentages should not be combined or treated as a direct comparison. Together, they leave a practical question open: when travel costs rise, how do companies decide which trips merit the investment, and what evidence do they use afterward?
Why are cost controls not the same as outcome measurement?
Policy compliance, booking approval, and supplier negotiation can help govern spend. They do not, on their own, show whether a trip changed an account, advanced a decision, or protected a customer relationship. That is an analytical distinction, not a claim that companies lack other internal measures.
Deloitte describes travel technology investment as one way companies manage costs while protecting trip volume or comfort. Whether newer planning tools, including AI-enabled tools, can improve the decision to travel is a separate question; the cited study does not answer it.
The same distinction matters in supplier selection. The Sales Traveler’s Sales-Ready work examines published commitments relevant to revenue travel. A published commitment is not proof of delivered service quality, and neither is a hotel rating evidence that a trip produced revenue.
Five questions to carry into 2027
These are questions for future measurement, not predictions about what companies will do:
- Will more companies require a written purpose or expected outcome before approving a customer-facing trip?
- What evidence, if any, will teams use to assess a trip after it happens, and over what time window?
- Can automated planning tools make supplier information easier to verify without implying that a recommendation proves performance?
- Will buyers distinguish a supplier’s documented commitments from observed service outcomes when choosing where to stay or meet?
- Will travel and meeting decisions be reviewed together when they serve the same customer objective?
Each question needs a stated population, a defined measure, and a source that can be checked. Until that evidence exists, adoption and commercial impact remain unproven.
What would count as stronger evidence?
A more useful account of trip value would state the decision being supported before booking, identify what changed after the trip, and distinguish observed outcomes from a traveler’s perception. It would also describe the comparison being made, such as what happened without the trip or with a different meeting format. Without that comparison, a post-trip result may be associated with travel without showing that travel caused it.
This note is an industry analysis, not a new trip-level outcome study. It brings a published industry forecast beside a limited first-party survey signal to clarify what each can and cannot establish. The central claim is modest: higher budgets make the quality of trip decisions more consequential, but the cited figures do not tell a company which trip is worth taking.
The Field Brief: sharp travel-ROI notes for the people who carry the quarter through airports. No signup, no email, nothing to unsubscribe from: read it free in the open archive.
Read the brief →